Medicine and the media

Fainting schoolgirls wipe $A1bn off market value of Gardasil producer

BMJ 2007; 334 doi: 10.1136/bmj.39238.479479.94 (Published 7 June 2007)
Cite this as: BMJ 2007;334:1195

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Simon Chapman, professor of public health,
  2. Ross MacKenzie, research officer
  1. School of Public Health, University of Sydney
  1. Correspondence to:S Chapmansc{at}med.usyd.edu.au

    Public health workers need to be as vigilant against one-sided media coverage of vaccination as they were against the disinformation spread by the tobacco industry

    On 22 May news broke that 25 girls at a Catholic high school in Melbourne who had just had their first injection of Gardasil, the vaccine against human papillomavirus (HPV), presented to the school's sick bay with symptoms that included headache, nausea, and dizziness. CSL, the vaccine's Australian developer, reports that four pupils were sent to hospital for further examination. It said, “One had chest pain and palpitations; she had a past history of these symptoms. She was discharged the same day. The second had hyperventilation paraesthesiae and was sent home the same day. The third and fourth had neurological symptoms and were admitted. The fourth girl had reported progressive muscular weakness. Overnight both got better and were seen by the neurologist in the morning who diagnosed non-organic illness.”

    Other than the mother of …

    Access to the full text of this article requires a subscription or payment

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL